Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Detail - Accrued and Other Liabilities (Details)

v3.7.0.1
Condensed Consolidated Financial Statements Detail - Accrued and Other Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Accrued and other liabilities [Abstract]    
Accrued payroll and other benefits $ 138 $ 1,582
Accrued clinical trial costs 389 743
Accrued incentive compensation 134  
Accrued legal and accounting fees 641 385
Other 760 1,505
Total $ 2,062 $ 4,215 [1]
[1] The condensed consolidated balance sheet as of December 31, 2016 has been derived from the audited consolidated financial statements as of that date included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.